Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB25FQHWV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,204
Award facts
- Contract value 100% obligated
- $17,203.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $17,203.98 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300mg dose in 2-pen/ml configuration. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of August 15, 2025, issued on August 14, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical supply vehicle running through December 2026 that enables AmerisourceBergen to provide a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally.
As a child contract under the SPE2DX IDC, this delivery order represents a specific pharmaceutical procurement for federal military medical needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, serves as a critical vendor for the Defense Logistics Agency's medical supply chain, consistently winning competitive awards for brand-name and generic medications across multiple therapeutic domains. The DLA's Pharmaceutical Prime Vendor Global Program structure allows for flexible procurement of essential medications like Cosentyx, which is used in military healthcare systems to support troops and service members worldwide.
Quick answers
Who was awarded contract SPE2DB25FQHWV?
SPE2DB25FQHWV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 14, 2025.
How much is contract SPE2DB25FQHWV worth?
The government has obligated $17,204 on SPE2DB25FQHWV.
Is contract SPE2DB25FQHWV an order under another contract?
Yes. SPE2DB25FQHWV is a delivery order under SPE2DB25D3005, an indefinite delivery contract.
Was contract SPE2DB25FQHWV competed?
The extent of competition for SPE2DB25FQHWV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award